Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 24, 2022

View Archived Issues

LBX2 is a marker of colon adenocarcinoma

Endonuclease V is a diagnostic and prognostic marker in colon adenocarcinoma

CDK9 inhibition as promising therapeutic strategy against HCC

Chinese researchers patent sigma-1 receptor agonists

Sichuan Haisco Pharmaceutical discloses new JAK inhibitors

Immunophage Biomedical presents new CCR8 antagonists

Shanghai Institute of Materia Medica identifies new S1PR1 agonists

Inventisbio Shanghai discloses GTPase KRAS mutant inhibitors

New approach integrates CAR-T cell immunotherapy with local activation of small-molecule prodrugs

Engineered virus-like particles for in vivo delivery of gene editing proteins

Oasmia advances its next-generation XR-18 drug delivery technology

IM-1761065, a novel biguanide with promising activity in models of glioblastoma

HS6ST2 predicts survival in PDAC

Anti-ANXA1 antibody MDX-124 shows promise in preclinical models of pancreatic cancer

Sorrento's STI-9167 neutralizes Omicron and Omicron (+R346k) variants of SARS-CoV-2

TACH-101 shows activity in gastric and colorectal cancer models

Small molecule improves AD neuropathology in mice

Juva Life advances JUVA-041 into preclinical development

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...